<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01476969</url>
  </required_header>
  <id_info>
    <org_study_id>CentralSouthU</org_study_id>
    <nct_id>NCT01476969</nct_id>
  </id_info>
  <brief_title>Effect of Remote Ischemic Perconditioning on Acute Kidney Injury in Adult Valve Replace</brief_title>
  <official_title>Effect of Remote Ischemic Perconditioning on Acute Kidney Injury in Adult Valve Replace</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central South University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central South University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Remote Ischemic Perconditioning is
      effective on Acute kidney injury in adult valve replacement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: Patients meeting the requirement will be randomized into 2 groups: the treatment
      group consisted of three 5-minute cycles left lower limb ischemia, induced by inflating a
      blood pressure cuff on the lower limb to 600 mmHg with an intervening 5 minutes of
      reperfusion, during which time the cuff was deflate; the control group consisted of placing
      an uninflated cuff on the left lower limb for 30 minutes. The postconditioning protocol was
      applied after the aortic cross-clamping. The clinical data of inotropes requirement,
      drainage, ventilation and intensive care time will be recorded. Venous blood samples will be
      taken perioperatively for detecting concentration of troponin I (cTnI), Myocardial enzyme,
      Renal function, Cystatin c, and High-sensitivity c-reactive protein(HS-CRP).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <primary_completion_date type="Anticipated">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal function</measure>
    <time_frame>within the first 48h after cardiac surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>concentration of troponin I (cTnI)</measure>
    <time_frame>within 48h after cardiac surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial enzyme</measure>
    <time_frame>within 48h after cardiac surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cystatin C</measure>
    <time_frame>within 48h after cardiac surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-sensitivity c-reactive protein(HS-CRP)</measure>
    <time_frame>within 48h after cardiac surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Rheumatic Disease of Heart Valve</condition>
  <condition>Ischemic Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>Manual Tourniquet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Remote ischemic postconditioning</intervention_name>
    <description>the treatment group consisted of three 4-minute cycles left lower limb ischemia,induced by inflating a blood pressure cuff on the lower limb to 600 mmHg with an intervening 4 minutes of reperfusion ,during which time the cuff was deflate;the control group consisted of placing an uninflated cuff on the left lower limb for 24 minutes.The postconditioning protocol was applied after the aortic cross-clamping.</description>
    <arm_group_label>Manual Tourniquet</arm_group_label>
    <other_name>Manual Tourniquet YZ-01</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  rheumatic heart valve disease requiring selective aortic or double valve(aortic and
             mitral valve) replacement

        Exclusion Criteria:

          -  infective endocarditis congenital valve disease previous cardiac surgery complicated
             with rereplace valve

          -  Renal dysfunction

          -  diabetes

          -  coronary artery disease

          -  hypertension

          -  peripheral vascular disease affecting the lower limb free of arteriovenous fistula

          -  receiving aspirin, corticosteroids, angiotensin-converting enzyme inhibitors or statin
             perioperatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luo Wanjun, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Central South University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luo Wanjun, M.D.</last_name>
    <phone>86-731-89753503</phone>
    <email>luo3478@yahoo.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lv Hongwei, M.D.</last_name>
    <phone>86-13467616975</phone>
    <email>hongweilv@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luo Wanjun, M.D.</last_name>
      <phone>86-731-89753503</phone>
      <email>luo3478@yahoo.cn</email>
    </contact>
    <contact_backup>
      <last_name>Lv Hongwei, M.D.</last_name>
      <phone>86-13467616975</phone>
      <email>hongweilv@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Luo Wanjun, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lv Hongwei, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2011</study_first_submitted>
  <study_first_submitted_qc>November 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2011</study_first_posted>
  <last_update_submitted>August 11, 2012</last_update_submitted>
  <last_update_submitted_qc>August 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central South University</investigator_affiliation>
    <investigator_full_name>Luo Wanjun</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Ischemia reperfusion injury</keyword>
  <keyword>Cardiopulmonary bypass</keyword>
  <keyword>Remote Ischemic Postconditioning</keyword>
  <keyword>Other Functional Disturbances Following Cardiac Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Collagen Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

